Heartland Group Holdings
- Short interest
- 0.04%
- −0.10 pp 30d
- as of 4 Feb 2025
- Reported shorts
- 380.9K
- Shares on issue
- 937.419M
Heartland Group Holdings (HGH) Short Interest
Heartland Group Holdings (ASX:HGH) had 0.04% of shares reported as short positions as of 4 Feb 2025, representing 380,872 shares. Heartland Group Holdings operates in the Banks industry. Source: ASIC short position report (T+4 delay).
Source: official ASIC short position report, T+4 delay. Methodology · Disclaimer — not financial advice.
Price & short interest
Toggle series, zoom, and compare · ASIC daily, T+4About Heartland Group Holdings
Heartland Group Holdings is a financial services provider specializing in banking products. The company focuses on providing simple and seamless banking experiences through innovative technology. Heartland has a strong market position in reverse mortgages in New Zealand and offers a range of savings and deposit products.
Company profile →Heartland Group Holdings (ASX:HGH) has 0.04% of its shares on issue reported as short positions as of 4 Feb 2025, or about 380,872 shares. Over the past 30 days that figure has fallen 0.10 percentage points, and over 90 days it has fallen 0.10 percentage points. Its highest recorded short interest was 0.85% in April 2023. HGH is classified in the Banks industry. All figures come from official ASIC short position reports, published with a four trading-day (T+4) delay.
Short interest
History & FAQ →Weekly context: The 10 most shorted ASX stocks — Week 41, 2026.
Strategy fit
How each stock picker strategy reads HGH today
- Zanger BreakoutWatchScore 42rank 172 of 1893
- CAN SLIMWatchScore 40rank 122 of 1549
- Minervini Trend TemplateWatchScore 34rank 448 of 1684
- Crowded-Short BreakoutWatchScore 15rank 619 of 1449
- Quality compoundersWatchScore 32rank 376 of 1660
Prices to 15 Oct 2026 · Mechanical readings of published rules, not recommendations · Not financial adviceFull strategy readings →
HGH fundamentals
In the year to 30 Jun 2026, Heartland Group Holdings (ASX:HGH) recorded revenue of NZ$367.6M and net profit after tax of NZ$93.2M. A year earlier it recorded revenue of NZ$319.1M and net profit after tax of NZ$38.8M. Year-on-year growth: revenue +15.2% (FY), EPS +138.9% (TTM). Net margin 25.4% (FY). Figures are in NZD, the company's reporting currency; source: ASX (Markit) and Yahoo Finance, as at 14 Oct 2026.
Full statements, ratios and filings are on the Financials tab. Not financial advice.
Latest HGH news
All news- Locksley fires up copper growth push across NSW heartland
theage · 15 Oct 2026
- Heartland publishes Notice of Meeting
asx · 14 Oct 2026
- Heartland confirms endorsement of TSB Heartland Bank CEO
asx · 1 Oct 2026
Company details
website
address
More Banks Stocks
Other shorted stocks in this sector
Be the first to discuss HGH
Start a research thread or post the first pulse update